HART NYLI Healthy Hearts ETF
Quote as of Aug 19, 2025 20:00 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Previous Close | 30.57 | Day Range | 30.63 – 30.67 |
| 52-Week Range | 26.85 – 33.54 | Volume | 164 |
| Avg Volume | 566 | AUM | $9.1M (Aug 26, 2026) |
| Expense Ratio | 0.45% | Yield (TTM) | — |
| NAV | 29.42 | Premium/Discount | +4.25% indicative |
| Inception | Jan 14, 2021 | Holdings | 64 |
| Issuer | NY Life Investments | Exchange | AMEX |
| Category | Healthcare | Index Tracked | Not stated in source data |
| CUSIP | 45409B321 | ISIN | US45409B3217 |
| Management | Passive / index-tracking (per issuer description) | ||
About this ETF
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the index, which was developed by IndexIQ LLC with Candriam Belgium S.A. acting as index consultant to IndexIQ. The index includes securities of large-, mid- and small-capitalization companies that trade in the U.S. and foreign markets, including emerging markets other than China, Egypt, India, Kuwait, Pakistan, Qatar, Saudi Arabia and United Arab Emirates.
Description from the fund data provider · profile as of Aug 26, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | +3.83% | +1.42% | -4.93% | +0.07% | -6.01% | +3.83% | — | — | +4.55% |
| Total return | +3.83% | +2.00% | -3.95% | +1.12% | -4.57% | +5.20% | — | — | +5.88% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Aug 19, 2025. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.45% | Annual cost of a $10,000 investment | $45.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Aug 18, 2025 — portfolio reporting date from the data provider; holdings are not live positions. 72 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | Alphabet Inc. Class A | GOOGL | 5.77% | 2.59K | $528.9K |
| 2 | Apple Inc. | AAPL | 5.61% | 2.22K | $513.7K |
| 3 | Johnson & Johnson | JNJ | 5.53% | 2.87K | $507.1K |
| 4 | AstraZeneca PLC | AZN.L | 5.29% | 3.08K | $484.4K |
| 5 | Novartis AG | NOVN.SW | 5.25% | 3.89K | $481.0K |
| 6 | Pfizer Inc. | PFE | 5.20% | 18.97K | $476.9K |
| 7 | UnitedHealth Group Incorporated | UNH | 4.90% | 1.48K | $448.7K |
| 8 | Abbott Laboratories | ABT | 4.80% | 3.34K | $439.5K |
| 9 | Boston Scientific Corporation | BSX | 4.77% | 4.23K | $436.7K |
| 10 | Eli Lilly and Company | LLY | 4.62% | 604 | $423.5K |
| 11 | Medtronic Plc | MDT | 3.81% | 3.75K | $348.9K |
| 12 | Novo Nordisk A/S Class B | NOVOB.CO | 3.60% | 6.45K | $330.1K |
| 13 | Sanofi SA | SAN | 3.59% | 3.31K | $329.0K |
| 14 | Bristol-Myers Squibb Company | BMY | 3.14% | 5.94K | $287.7K |
| 15 | NIKE Inc. Class B | NKE | 2.86% | 3.40K | $261.7K |
| 16 | Elevance Health Inc. | ELV | 2.25% | 665 | $205.9K |
| 17 | HCA Healthcare Inc | HCA | 2.23% | 516 | $204.2K |
| 18 | Edwards Lifesciences Corporation | EW | 1.45% | 1.69K | $132.5K |
| 19 | Garmin Ltd. | GRMN | 1.20% | 475 | $110.4K |
| 20 | adidas AG | ADS | 1.03% | 487 | $94.8K |
| 21 | General Mills Inc. | GIS | 0.87% | 1.61K | $79.9K |
| 22 | Rhythm Pharmaceuticals Inc. | RYTM | 0.77% | 726 | $70.9K |
| 23 | Fresenius SE & Co. KGaA | FRE | 0.71% | 1.21K | $64.9K |
| 24 | Koninklijke Philips N.V. | PHIA | 0.67% | 2.25K | $61.6K |
| 25 | Bumrungrad Hospital Public Co. Ltd. | BH.BK | 0.64% | 10.45K | $59.0K |
Click a ticker to see every ETF that owns it.
Sector Exposure
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | — | Paid (last 12 months) | — |
| Frequency | Quarterly | SEC yield | Not provided by our data source — see the issuer page |
| Last ex-date | Jun 20, 2025 | Last payment | $0.1660 (Jun 26, 2025) |
| Growth 1Y | — | Growth 3Y / 5Y (ann.) | — / — |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Jun 20, 2025 | Jun 20, 2025 | Jun 26, 2025 | $0.1660 |
| Mar 21, 2025 | Mar 21, 2025 | Mar 27, 2025 | $0.1508 |
| Dec 20, 2024 | Dec 20, 2024 | Dec 26, 2024 | $0.0650 |
| Sep 20, 2024 | Sep 20, 2024 | Sep 25, 2024 | $0.0851 |
| Jun 21, 2024 | Jun 21, 2024 | Jun 26, 2024 | $0.1065 |
| Mar 15, 2024 | Mar 18, 2024 | Mar 21, 2024 | $0.1143 |
| Dec 15, 2023 | Dec 18, 2023 | Dec 21, 2023 | $0.0552 |
| Sep 15, 2023 | Sep 18, 2023 | Sep 21, 2023 | $0.0890 |
| Jun 16, 2023 | Jun 20, 2023 | Jun 23, 2023 | $0.0873 |
| Mar 17, 2023 | Mar 20, 2023 | Mar 23, 2023 | $0.1166 |
| Dec 16, 2022 | Dec 19, 2022 | Dec 22, 2022 | $0.0610 |
| Sep 16, 2022 | Sep 19, 2022 | Sep 22, 2022 | $0.0570 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
| Volatility 1Y / 3Y | — / — | Sharpe 1Y / 3Y | — / — |
| Max drawdown 1Y / 3Y | — / — | Sortino 1Y | — |
| Beta vs S&P 500 (3Y) | 0.561 | Correlation vs S&P 500 (1Y) | — |
| Downside deviation 1Y | — | Risk-free rate used | 3.72% (3M T-bill, FRED) |
Computed by ETF Explorer from daily dividend-adjusted closes; volatility and drawdown are annualized/period figures; S&P 500 exposure proxied by SPY. As of Aug 26, 2026. Formulas →
Liquidity
| Volume today | 164 | Average volume | 566 |
| AUM | $9.1M | Premium/Discount | +4.25% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV — an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source — review them before investing.
Latest News for HART
No articles mention this fund directly in the last 7 days — showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.